
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Usage of Histamine Type 1 Receptor Antagonist and Risk of Dementia in the Elderly: A Nationwide Cohort Study
Chuan-Chi Yang, Wu‐Chien Chien, Chi‐Hsiang Chung, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 3
Chuan-Chi Yang, Wu‐Chien Chien, Chi‐Hsiang Chung, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 3
Showing 3 citing articles:
Histamine Receptors Endocytosis and Signaling
Ornella Conte, Mariela M. Gironacci
The Receptors (2025), pp. 235-255
Closed Access
Ornella Conte, Mariela M. Gironacci
The Receptors (2025), pp. 235-255
Closed Access
Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications
Nagaraju Bandaru, Sarad Pawar Naik Bukke, Veera Mani Deepika Pedapati, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 2, pp. 22-22
Open Access
Nagaraju Bandaru, Sarad Pawar Naik Bukke, Veera Mani Deepika Pedapati, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 2, pp. 22-22
Open Access
Alzheimer’s disease and clinical trials
Deepraj Paul, Rohini Agrawal, Swati Singh
Journal of Basic and Clinical Physiology and Pharmacology (2024) Vol. 35, Iss. 1-2, pp. 31-44
Closed Access | Times Cited: 2
Deepraj Paul, Rohini Agrawal, Swati Singh
Journal of Basic and Clinical Physiology and Pharmacology (2024) Vol. 35, Iss. 1-2, pp. 31-44
Closed Access | Times Cited: 2
The H4R antagonist, JNJ-7777120 treatments ameliorate mild traumatic brain injury by reducing oxidative damage, inflammatory and apoptotic responses through blockage of the ERK1/2/NF-κB pathway in a rat model
Ece Sağlam-Çifci, İlker Güleç, Aslıhan Şengelen, et al.
Experimental Neurology (2024) Vol. 385, pp. 115133-115133
Closed Access
Ece Sağlam-Çifci, İlker Güleç, Aslıhan Şengelen, et al.
Experimental Neurology (2024) Vol. 385, pp. 115133-115133
Closed Access